From streamlining clinical trials to evaluating drug repurposing possibilities for new patient populations and addressing critical supply chain challenges, 2024 will be the year artificial
In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space.
In the final instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Cencora’s SVP of international commercialisation, Sandra Anderson, and
Created based industry demand, this meeting is dedicated to bringing together 80+ industry experts who will optimize strategic sourcing processes to establish more reliable supply chains that will get allow us to get more radiopharmaceuticals to patients than ever before, on time and with maximum visibility over the supply chain for all stakeholders.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.